Steris STE
NYSE STE
$215.02 -3.42 (-1.57%)
As of: Sep 9, 2026 · 3:59 PM EDT

Steris (STE) Cash from Financing Activities (2018 - 2026)

Steris (STE) posted Cash from Financing Activities of -$213.5 million for Q2 2026, down 118.08% on a QoQ basis from -$97.9 million in Q1 2026, and little changed year-over-year from -$213.9 million in Q2 2025.

Analysis

Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Steris has reported Cash from Financing Activities for 9 years, with the latest figure at -$213.5 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities changed 0.19% year-over-year to -$213.5 million in Q2 2026; TTM through Jun 2026 was -$568.6 million, a 27.71% increase from a year earlier, with the FY2026 full-year figure at -$568.2 million, up 63.86% from the prior year.
  • Cash from Financing Activities was -$213.5 million for Q2 2026 at Steris, down from -$97.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $470.2 million in Q3 2023, with the low at -$998.9 million in Q2 2024.
  • Average Cash from Financing Activities over 5 years is -$178.5 million, with a median of -$179.5 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities jumped 1146.13% in 2023, then tumbled 367.57% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$120.4 million in 2022, then tumbled by 64.43% to -$198.0 million in 2023, then fell by 8.29% to -$214.4 million in 2024, then soared by 54.29% to -$98.0 million in 2025, then sank by 117.86% to -$213.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$213.5 million (Q2 2026), -$97.9 million (Q1 2026), and -$98.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -287.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -343.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -300,000.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -510.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -607.30 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -213.50 Mn
10 Zimmer Biomet Holdings 18.70 Bn 18.30 Bn 1.54 Bn -271.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -213.50 Mn
Mar 31, 2026 -97.90 Mn
Dec 31, 2025 -98.00 Mn
Sep 30, 2025 -159.20 Mn
Jun 30, 2025 -213.10 Mn
Mar 31, 2025 -178.10 Mn
Dec 31, 2024 -214.40 Mn
Sep 30, 2024 -181.00 Mn
Jun 30, 2024 -998.90 Mn
Mar 31, 2024 -143.78 Mn
Dec 31, 2023 -197.99 Mn
Sep 30, 2023 470.21 Mn
Jun 30, 2023 -213.64 Mn
Mar 31, 2023 -191.95 Mn
Dec 31, 2022 -120.41 Mn
Sep 30, 2022 -44.95 Mn
Jun 30, 2022 -141.41 Mn
Mar 31, 2022 -274.61 Mn
Dec 31, 2021 -189.27 Mn
Sep 30, 2021 -239.11 Mn